Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2024 Filed May 10, 2024 18:04 UTC |
Grant Jeremy TDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012911 · form4-05102024_100529.xml · derivative · entry 2 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 18:04 UTC |
Grant Jeremy TDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012911 · form4-05102024_100529.xml · nonDerivative · entry 1 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,305 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:12 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012919 · form4-05102024_100512.xml · derivative · entry 2 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:12 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012919 · form4-05102024_100512.xml · nonDerivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,416 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:09 UTC |
MITCHELL DEAN JDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012915 · form4-05102024_100546.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:09 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012915 · form4-05102024_100546.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,555 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:02 UTC |
BROSHY ERANDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012908 · form4-05102024_100548.xml · derivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:02 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012908 · form4-05102024_100548.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,555 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:10 UTC |
O'Connor DonalDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012917 · form4-05102024_100546.xml · derivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:10 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012917 · form4-05102024_100546.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,555 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:06 UTC |
GRAY SUSANNAHDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012913 · form4-05102024_100550.xml · derivative · entry 2 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:06 UTC |
GRAY SUSANNAHDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012913 · form4-05102024_100550.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,488 Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:01 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 23,576 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001415889-24-012906 · form4-05102024_100555.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576 Underlying: Ordinary Shares · 23,576 shares Expires 2034-05-07 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:01 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 10,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012906 · form4-05102024_100555.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,331 Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:19 UTC |
Samaha Eli10% owner
|
PurchaseCOM | 499,324 | $8.75 | $4,369,085.00 |
DisclosureSEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,511,350 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:19 UTC |
Samaha Eli10% owner
|
PurchaseCOM | 999,800 | $8.75 | $8,748,250.00 |
DisclosureSEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,012,026 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 22:13 UTC |
Miller AineSVP, DEV & HEAD OF IRE OFFICE
|
GrantOrdinary Shares | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010324 · form4-04042024_100429.xml · nonDerivative · entry 1 Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,034 Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 22:11 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
GrantOrdinary Shares | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010322 · form4-04042024_100443.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,684 F1 · shares: On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 22:09 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
GrantOrdinary Shares | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010320 · form4-04042024_100416.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,233 Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 22:17 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GrantOrdinary Shares | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010328 · form4-04042024_100427.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,850,573 F1 · shares: On April 2, 2024, the reporting person was granted 300,000 RSUs. 150,000 RSUs are subject to service-based vesting conditions and the remaining 150,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 22:15 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
GrantOrdinary Shares | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010326 · form4-04042024_100421.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,636 F1 · shares: On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:06 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GiftOrdinary Shares | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 4 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian Disclosed balance after: 3,900 F3 · kind: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. F4 · ownership.nature: The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:06 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GiftOrdinary Shares | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 3 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,550,573 F3 · kind: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:06 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GiftOrdinary Shares | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 2 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,554,473 F2 · kind: Bona Fide Gift. No compensation was given to the donor for the gifting of shares. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:06 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GrantOrdinary Shares | 2,704 | $8.64 | $23,362.56 |
DisclosureSEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,561,473 F1 · kind: Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on March 15, 2024. Transaction was with the Issuer and did not involve an open market transaction. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 01:04 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
SaleOrdinary Shares | 1,254 | $8.71 | $10,922.34 |
DisclosureSEC source: 0001415889-24-004958 · form4-02232024_010211.xml · nonDerivative · entry 2 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,733 F2 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:10 UTC |
Miller AineSVP, DEV & HEAD OF IRE OFFICE
|
Tax withholdingOrdinary Shares | 11,782 | $8.92 | $105,095.44 |
DisclosureSEC source: 0001415889-24-004964 · form4-02232024_010200.xml · nonDerivative · entry 1 Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,534 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:08 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 17,595 | $8.92 | $156,947.40 |
DisclosureSEC source: 0001415889-24-004962 · form4-02232024_010253.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,684 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:04 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 18,219 | $8.92 | $162,513.48 |
DisclosureSEC source: 0001415889-24-004958 · form4-02232024_010211.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,987 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:14 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 37,196 | $8.92 | $331,788.32 |
DisclosureSEC source: 0001415889-24-004968 · form4-02232024_010235.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558,769 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:11 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 17,036 | $8.92 | $151,961.12 |
DisclosureSEC source: 0001415889-24-004966 · form4-02232024_010249.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,636 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 01:06 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
Tax withholdingOrdinary Shares | 19,294 | $8.92 | $172,102.48 |
DisclosureSEC source: 0001415889-24-004960 · form4-02232024_010210.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,915 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 18:09 UTC |
Grant Jeremy TDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,578 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001415889-23-016943 · form4-12262023_111258.xml · derivative · entry 4 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,578 Underlying: Ordinary Shares · 6,578 shares Expires 2033-12-21 F2 · derivative.exercise_date: This option shall vest monthly over four months of service from the date of grant and will vest in full upon earlier of the four-month anniversary of Jeremy Grant's appointment to the Board or the date of Company's 2024 annual meeting of Shareholders. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 18:09 UTC |
Grant Jeremy TDirector
|
GrantShare Option (Right to Buy) · Derivative | 19,734 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001415889-23-016943 · form4-12262023_111258.xml · derivative · entry 3 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,734 Underlying: Ordinary Shares · 19,734 shares Expires 2033-12-21 F1 · derivative.exercise_date: The option vests monthly over 24 months of service from the date of grant. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 18:09 UTC |
Grant Jeremy TDirector
|
GrantOrdinary Shares | 2,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016943 · form4-12262023_111258.xml · nonDerivative · entry 2 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,768 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 18:09 UTC |
Grant Jeremy TDirector
|
GrantOrdinary Shares | 8,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016943 · form4-12262023_111258.xml · nonDerivative · entry 1 Grant Jeremy T · CIK 0002004368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,826 Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 23:07 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
SaleOrdinary Shares | 1,378 | $10.29 | $14,179.62 |
DisclosureSEC source: 0001415889-23-015446 · form4-11222023_111131.xml · nonDerivative · entry 2 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 331,206 F2 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:11 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 7,363 | $10.37 | $76,354.31 |
DisclosureSEC source: 0001415889-23-015450 · form4-11222023_111146.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,279 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. F2 · balance_after: Includes 345 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2023. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:07 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 7,982 | $10.37 | $82,773.34 |
DisclosureSEC source: 0001415889-23-015446 · form4-11222023_111131.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332,584 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:16 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 15,804 | $10.37 | $163,887.48 |
DisclosureSEC source: 0001415889-23-015454 · form4-11222023_111107.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,595,965 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:14 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 6,187 | $10.37 | $64,159.19 |
DisclosureSEC source: 0001415889-23-015452 · form4-11222023_111102.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,672 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 23:10 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
Tax withholdingOrdinary Shares | 12,630 | $10.37 | $130,973.10 |
DisclosureSEC source: 0001415889-23-015448 · form4-11222023_111154.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,209 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 23:16 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,482 | $10.22 | $25,366.04 |
DisclosureSEC source: 0001415889-23-015228 · form4-11162023_111124.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,839 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| October 30, 2023 Filed Nov 1, 2023 22:35 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
GrantOrdinary Shares | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014680 · form4-11012023_101136.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,321 F1 · shares: On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 22:54 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,482 | $9.03 | $22,412.46 |
DisclosureSEC source: 0001415889-23-014412 · form4-10182023_101010.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,321 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:08 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,482 | $9.89 | $24,546.98 |
DisclosureSEC source: 0001415889-23-013342 · form4-09182023_100948.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,803 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 22:05 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
SaleOrdinary Shares | 1,807 | $9.47 | $17,112.29 |
DisclosureSEC source: 0001415889-23-012621 · form4-08242023_100801.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 340,566 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 22:15 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 8,912 | $9.70 | $86,446.40 |
DisclosureSEC source: 0001415889-23-012517 · form4-08222023_100856.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,297 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 22:10 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 10,460 | $9.70 | $101,462.00 |
DisclosureSEC source: 0001415889-23-012510 · form4-08222023_100816.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,373 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 22:19 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 15,804 | $9.70 | $153,298.80 |
DisclosureSEC source: 0001415889-23-012522 · form4-08222023_100811.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,611,769 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.